N-(2-((3-Acetylphenyl)(2-hydroxyethyl)amino)-4'-methyl-[4,5'-bithiazol]-2'-yl)acetamide

ID: ALA4531023

PubChem CID: 155546020

Max Phase: Preclinical

Molecular Formula: C19H20N4O3S2

Molecular Weight: 416.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1nc(C)c(-c2csc(N(CCO)c3cccc(C(C)=O)c3)n2)s1

Standard InChI:  InChI=1S/C19H20N4O3S2/c1-11-17(28-18(20-11)21-13(3)26)16-10-27-19(22-16)23(7-8-24)15-6-4-5-14(9-15)12(2)25/h4-6,9-10,24H,7-8H2,1-3H3,(H,20,21,26)

Standard InChI Key:  ZAAVGWLFVJKADF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   19.9457  -16.0409    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   19.2844  -15.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5343  -14.7821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3529  -14.7821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6069  -15.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3981  -15.7719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0342  -15.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7175  -15.7018    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.5057  -16.4925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6891  -16.5372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.0851  -17.0719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8763  -16.8600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0886  -16.0687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8767  -15.8588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4563  -16.4384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2440  -17.2246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4551  -17.4388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0886  -15.0675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5093  -14.4882    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.8799  -14.8556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8732  -17.8590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4525  -18.4384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2406  -19.2296    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.7643  -14.0747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4932  -15.7719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9138  -15.1926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1226  -15.4045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1257  -14.4013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  5  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  6  1  0
  9 11  1  0
 11 12  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 12 17  1  0
 14 18  1  0
 18 19  2  0
 18 20  1  0
 11 21  1  0
 21 22  1  0
 22 23  1  0
  4 24  1  0
  2 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4531023

    ---

Associated Targets(Human)

RD (1212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PI4KB Tchem PI4-kinase beta subunit (1593 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Enterovirus A71 (1246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B3 (1096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhinovirus A2 (409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhinovirus B14 (1052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.53Molecular Weight (Monoisotopic): 416.0977AlogP: 3.87#Rotatable Bonds: 7
Polar Surface Area: 95.42Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.98CX Basic pKa: 0.43CX LogP: 2.59CX LogD: 2.49
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.70

References

1. Tassini S, Langron E, Delang L, Mirabelli C, Lanko K, Crespan E, Kissova M, Tagliavini G, Fontò G, Bertoni S, Palese S, Giorgio C, Ravanetti F, Ragionieri L, Zamperini C, Mancini A, Dreassi E, Maga G, Vergani P, Neyts J, Radi M..  (2019)  Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †.,  62  (23): [PMID:31729878] [10.1021/acs.jmedchem.9b01416]

Source